Torphasol vet.

1 x 20 ml

Liquid for injection, solution

Active substance

Butorphanol (Butorphanol tartrate) : 10 mg/ml

ATC code

QN02AF01 Butorphanol

QN02AF Morphinan derivatives

QN02A Opioids

QN02 Analgesics

QN Nervous system

Species

Horses

Indications

For short term relief of pain associated with colic of gastrointestinal tract origin. For information on the onset and duration of analgesia that can be expected following treatment, see section 5.1.

For sedation in combination with certain α2-adrenoceptor agonists (see section 4.9).

Dose to be administered and administration route

For intravenous administration only.

For analgesia:

Dose rate: 100 μg butorphanol per kg bodyweight (BW) (equivalent to 1 ml for 100 kg BW), by intravenous injection. Butorphanol is intended for use where short duration analgesia is required. The dose may be repeated as required. The need for and timing of repeat treatment will be based on clinical response. For information on the onset and duration of analgesia see section 5.1. For cases where longer duration analgesia is likely to be required, an alternative therapeutic agent should be used.

For sedation in combination with detomidine hydrochloride:

A dose rate of 12 μg detomidine hydrochloride per kg BW should be given intravenously followed within 5 minutes by a dose rate of 25 μg butorphanol per kg BW (equivalent to 0.25 ml for 100 kg BW) intravenously.

For sedation in combination with romifidine:

A dose of 40-120 μg romifidine per kg BW followed within 5 minutes by a dose rate of 20 μg butorphanol per kg BW (equivalent to 0.2 ml for 100 kg BW) should be administered intravenously.

For sedation in combination with xylazine:

A dose rate of 500 μg xylazine per kg BW followed immediately by a dose of 25-50 μg butorphanol per kg BW (equivalent to 0.25-0.5 ml per 100 kg) should be administered intravenously.